Federated Hermes
MLTX icon

Federated Hermes’s MoonLake Immunotherapeutics MLTX Stock Holding History

Federated Hermes’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,248,573
Closed -$58.9M – 2187
2025
Q2 		$58.9M Sell
1,248,573
-20,778
-2% -$846K 0.11% 230
2025
Q1 		$49.6M Sell
1,269,351
-10,701
-0.8% -$461K 0.11% 238
2024
Q4 		$69.3M Buy
1,280,052
+149,724
+13% +$7.65M 0.15% 182
2024
Q3 		$57M Buy
1,130,328
+1,900
+0.2% +$89K 0.13% 214
2024
Q2 		$49.6M Buy
1,128,428
+28,672
+3% +$1.21M 0.12% 221
2024
Q1 		$55.2M Buy
1,099,756
+39,230
+4% +$2.13M 0.13% 210
2023
Q4 		$64M Sell
1,060,526
-23,724
-2% -$1.22M 0.16% 163
2023
Q3 		$61.8M Sell
1,084,250
-85,249
-7% -$4.71M 0.16% 159
2023
Q2 		$59.6M Buy
1,169,499
+365,000
+45% +$9.82M 0.15% 175
2023
Q1 		$17.2M Buy
+804,499
New +$13.5M 0.04% 433

Other funds holding MLTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return